VENTYX BIOSCIENCES
Ventyx Biosciences is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. Ventyx’s clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1 peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions.
VENTYX BIOSCIENCES
Social Links:
Industry:
Biopharma Biotechnology
Founded:
2018-01-01
Address:
Encinitas, California, United States
Country:
United States
Website Url:
http://www.ventyxbio.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
441.6 M USD
Technology used in webpage:
Euro Google Maps IPv6 COVID-19 Akamai Hosted
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
EpiVario
EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Harmony Biosciences
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Redmile Group
Redmile Group investment in Post-IPO Equity - Ventyx Biosciences
Surveyor Capital
Surveyor Capital investment in Post-IPO Equity - Ventyx Biosciences
Farallon Capital Management
Farallon Capital Management investment in Post-IPO Equity - Ventyx Biosciences
Cormorant Asset Management
Cormorant Asset Management investment in Post-IPO Equity - Ventyx Biosciences
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - Ventyx Biosciences
CaaS Capital Management
CaaS Capital Management investment in Post-IPO Equity - Ventyx Biosciences
Acuta Capital Partners
Acuta Capital Partners investment in Post-IPO Equity - Ventyx Biosciences
Boxer Capital
Boxer Capital investment in Post-IPO Equity - Ventyx Biosciences
Redmile Group
Redmile Group investment in Post-IPO Equity - Ventyx Biosciences
Logos Capital
Logos Capital investment in Post-IPO Equity - Ventyx Biosciences
Key Employee Changes
| Date | New article |
|---|---|
| 2024-05-16 | Ventyx Biosciences gets new operations chief |
| 2022-05-09 | Ventyx Biosciences Announces Appointment of William Sandborn, MD, as President and Chief Medical Officer |
Official Site Inspections
http://www.ventyxbio.com Semrush global rank: 3.56 M Semrush visits lastest month: 3.67 K
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ventyx Biosciences"
Investors & News – Ventyx Biosciences, Inc.
Oct 15, 2024 · The Investor Relations website contains information about Ventyx Biosciences, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Ventyx Biosciences - Crunchbase Company Profile
Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders. Ventyx Biosciences has seen a surge in its stock price, attributed to Piper's recognition of its …See details»
Investor FAQs - Ventyx Biosciences, Inc.
Where is Ventyx Biosciences incorporated? The company is incorporated in Delaware. When did the company go public? Our initial public offering (IPO) occurred on October 21, 2021. Which …See details»
Ventyx Biosciences Reports First Quarter 2024 Financial Results …
May 9, 2024 · Our current pipeline includes internally discovered clinical programs targeting NLRP3, S1P1R and TYK2, positioning us to become a leader in the development of oral …See details»
Ventyx Biosciences - PitchBook
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. …See details»
Ventyx Biosciences - LinkedIn
We are a biotechnology company with a diverse portfolio of best-in-class highly differentiated clinical and pre-clinical stage programs focused on high value targets.See details»
Ventyx Biosciences Raises $114 Million Financing led …
Mar 9, 2021 · Ventyx Biosciences, Inc. is a clinical-stage biotechnology company advancing a broad pipeline of potent and selective small-molecule drug candidates to treat inflammatory diseases and...See details»
Ventyx Biosciences - Overview, News & Similar companies
Jun 20, 2024 · Ventyx Biosciences contact info: Phone number: (760) 593-4832 Website: www.ventyxbio.com What does Ventyx Biosciences do? Ventyx Biosciences, Inc., found in …See details»
Org Chart Ventyxbio - The Official Board
Unfortunately, you don't own enough credit to see this new org chart. To continue, you can add a name in one of the org charts you recently viewed or test our Premium membership.See details»
News Releases - Ventyx Biosciences, Inc.
Nov 12, 2024 · The Investor Relations website contains information about Ventyx Biosciences, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Ventyx Biosciences to Participate in Three Upcoming
Nov 12, 2024 · Ventyx is a clinical-stage biopharmaceutical company focused on developing innovative oral medicines for patients living with autoimmune and inflammatory disorders.See details»
Ventyx Biosciences Announces Initiation of Dosing in a
ENCINITAS, Calif., June 14, 2023 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel …See details»
Ventyx Biosciences to Present Results of the Phase 2 Trial of …
Feb 22, 2024 · Ventyx is a clinical-stage biopharmaceutical company focused on developing innovative oral medicines for patients living with autoimmune and inflammatory disorders.See details»
Ventyx Biosciences Raises $114 Million Financing led by venBio …
Mar 9, 2021 · Ventyx Biosciences, Inc. is a clinical-stage biotechnology company advancing a broad pipeline of potent and selective small-molecule drug candidates to treat inflammatory …See details»
Ventyx Biosciences Reports Clinical Data for its NLRP3 Inhibitor ...
SAN DIEGO, March 11, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral …See details»
Ventyx Biosciences to Participate in the Oppenheimer 34th Annual ...
Feb 6, 2024 · A webcast of the presentation will be available in the Investors and News section of the Ventyx website at www.ventyxbio.com. A webcast replay will also be available on this …See details»
Ventyx Biosciences, Inc. (VTYX) Stock Price, News, Quote & History ...
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. The company's lead clinical...See details»
Ventyx Biosciences Reports Full Year 2021 Financial Results and ...
ENCINITAS, Calif., March 23, 2022 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX), (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel …See details»
Ventyx Biosciences, Inc. (VTYX) - Stock Analysis
2 days ago · Get a real-time Ventyx Biosciences, Inc. (VTYX) stock price quote with breaking news, financials, statistics, charts and more.See details»
Ventyx Biosciences Announces Key Appointments and Closing of …
ENCINITAS, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (“Ventyx” or the “Company”), a clinical-stage biopharmaceutical company focused on advancing new …See details»